Ceramide testing provides algorithmic score for heart attack risk
Mayo Clinic Laboratories offers a ceremide test to advise patients and their clinicians of the potential risk of heart attack. Using liquid chromatography-mass spectrometry technology, the test renders an algorithmic score after sorting through molecular compounds of ceramides of cardiovascular interest. Ceramide testing can be used alongside traditional blood tests to investigate risk factors of coronary artery disease.
For Mayo Clinic patient Stephanie Blendermann, who lost three of her sisters in their 40s and 50s to heart attacks, ceramide testing provided additional answers to be more aggressive and proactive in preventing heart disease.